ArticleInvestigational new drugs2024

Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.

Andrew J Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.